The mitochondrial respiratory chain is a powerful source of reactive oxygen species (ROS), which is considered as the pathogenic agent of many diseases and of aging. We have investigated the role of complex I in superoxide radical production and found by the combined use of specific inhibitors of complex I that the one-electron donor to oxygen in the complex is a redox center located prior to the sites where three different types of Coenzyme Q (CoQ) competitors bind, to be identified with an Fe–S cluster, most probably N2, or possibly an ubisemiquinone intermediate insensitive to all the above inhibitors. Short-chain Coenzyme Q analogs enhance superoxide formation, presumably by mediating electron transfer from N2 to oxygen. The clinically used CoQ analog, idebenone, is particularly effective, raising doubts on its safety as a drug. Cells counteract oxidative stress by antioxidants. CoQ is the only lipophilic antioxidant to be biosynthesized. Exogenous CoQ, however, protects cells from oxidative stress by conversion into its reduced antioxidant form by cellular reductases. The plasma membrane oxidoreductase and DT-diaphorase are two such systems, likewise, they are overexpressed under oxidative stress conditions.
Get full access to this article
View all access options for this article.
References
1.
Diplock AT. Antioxidants and disease prevention. Mol Aspects Med15:293–376, 1994.
2.
Harman D. The aging process. Proc Natl Acad Sci USA78:7124–7128, 1981.
3.
Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA91:10771–10778, 1994.
4.
Lenaz G. Role of mitochondria in oxidative stress and aging. Biochim Biophys Acta1366:53–67, 1998.
5.
Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol11:298–300, 1956.
6.
Harman D. Free radicals in aging. Mol Cell Biochem84:55–61, 1988.
7.
Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev59:527–605, 1979.
8.
Ernster L. Lipid peroxidation in biological membranes: Mechanisms and implications. In: Yagi K, Ed. Active Oxygen, Lipid Peroxides and Antioxidants. K. Yagi, Ed. Boca Raton, FL: CRC Press, pp1–38, 1993.
9.
Miquel J, Economos AC, Fleming J, Johnson JE Jr. Mitochondrial role in cell aging. Exp Gerontol15:575–591, 1980.
10.
Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lanceti:642–645, 1989.
11.
Ozawa T. Genetic and functional changes in mitochondria associated with aging. Physiol Rev77:425–464, 1997.
12.
Lenaz G, Bovina C, Castelluccio C, Fato R, Formiggini G, Genova ML, Marchetti M, MerloPich M, Pallotti F, Parenti Castelli G, Biagini, G. Mitochondrial complex I defects in aging. Mol Cell Biochem174:329–333, 1997.
13.
Kacser A, Burns JA. Molecular democracy: Who shares the controls? Biochem Soc Trans7:1149–1160, 1979.
14.
Capaldi RA. Arrangement of proteins in the mitochondrial inner membrane. Biochim Biophys Acta694:291–306, 1982.
15.
Davey GP, Clark JB. Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J Neurochem66:1617–1624, 1996.
16.
Moreno-Sanchez R, DeVars S, Lopez-Gomez F, Uribe A, Corona N. Distribution of control of oxidative phosphorylation in mitochondria oxidizing NAD-linked substrates. Biochim Biophys Acta1060:284–292, 1991.
17.
Kuznetsov AV, Winkler K, Kirches E, Lins H, Feistener H, Kunz WS. Application of inhibitor titrations for the detection of oxidative phosphorylation defects in saponin-skinned muscle fibers of patients with mitochondrial diseases. Biochim Biophys Acta1360:142–150, 1997.
18.
Ventura B, Genova ML, Bovina C, Formiggini G, Lenaz G. Control of oxidative phosphorylation by Complex I in rat liver mitochondria: Implications for aging. Biochim Biophys Acta1553:249–260, 2002.
19.
Degli Esposti M, Carelli V, Ghelli A, Ratta M, Crimi M, Sangiorgi S, Montagna P, Lenaz G, Lugaresi E, Cortelli P. Functional alterations of mitochondrially encoded ND-4 subunit associated with Leber’s hereditary optic neuropathy. FEBS Lett352:375–379, 1994.
20.
Merlo Pich M, Bovina C, Formiggini G, Cometti GG, Ghelli A, Parenti Castelli G, Genova ML, Marchetti M, Semeraro S, Lenaz G. Inhibitor sensitivity of respiratory complex I in human platelets: A possible biomarker of ageing. FEBS Lett380:176–178, 1996.
21.
Genova ML, Bovina C, Marchetti M, Pallotti F, Tietz C, Biagini G, Pugnaloni A, Viticchi C, Gorini A, Villa RF, Lenaz G. Decrease of rotenone inhibition as a sensitive parameter of complex I damage in brain non-synaptic mitochondria of aged rats. FEBS Lett410:467–469, 1997.
22.
Fridovich I. Superoxide dismutases. Adv Enzymol58:61–97, 1986.
23.
Richter C. Do mitochondrial DNA fragments promote cancer and aging? FEBS Lett241:1–5, 1988.
24.
Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J134:707–716, 1973.
25.
Skulachev VP. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Q Rev Biophys29:169–202, 1996.
26.
Nohl H, Jordan W. The mitochondrial site of superoxide formation. Biochem Biophys Res Commun138:533–539, 1986.
27.
Turrens JF, Alexandre A, Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys237:408–414, 1985.
28.
Degli Esposti M, Ballester F, Timoneda J, Crimi M, Lenaz G. The oxidation of ubiquinol by the isolated ‘Rieske’ iron- suplhur protein in solution. Arch Biochem Biophys283:258–265, 1990.
29.
Trumpower BL. New concepts on the role of ubiquinone in the mitochondrial respiratory chain. J Bioenerg Biomembr13:1–24, 1981.
30.
Nohl H, Gille L, Schönheit K, Liu Y. Conditions allowing redox-cycling ubisemiquinone in mitochondria to establish a direct redox couple with molecular oxygen. Free Rad Biol Med20:207–213, 1996.
31.
Beyer RE, Ernster L. The antioxidant role of Coenzyme Q. In: Lenaz G, Barnobei O, Robbi A, Battino M, Eds. Highlights of Ubiquinone Research. London: Taylor & Francis, pp191–213, 1990.
32.
Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta1271:195–204, 1995.
33.
Takeshige K, Takayanagi K, Minakami S. Biochemical, physiological and medical aspects of ubiquinone function. In: Yamamura Y, Folkers K, Ito PL, Eds. Biomedical and Clinical Aspects of Coenzyme Q. Amsterdam: Elsevier, Vol. 2: pp15–26, 1980.
34.
Cadenas E, Boveris A, Ragan CI, Stoppani AOM. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch Biochem Biophys180:248–257, 1977.
35.
Degli Esposti M, Ngo A, McMullen GL, Ghelli A, Sparla F, Benelli B, Ratta M, Linnane AW. The specificity of mitochondrial complex I for ubiquinones. Biochem J313:327–334, 1996.
36.
Glinn MA, Lee CP, Ernster L. Pro- and anti-oxidant activities of the mitochondrial respiratory chain: Factors influencing NAD(P)H-induced lipid peroxidation. Biochim Biophys Acta1318:246–254, 1997.
37.
Davies KJA, Doroshow JH. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem261:3060–3067, 1986.
38.
Degli Esposti M, Ngo A, Ghelli A, Benelli B, Carelli V, McLennan H, Linnane AW. The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria. Arch Biochem Biophys330:395–400, 1996.
39.
Cadenas E, Hochstein P, Ernster L. Pro- and antioxidant functions of quinones and quinone reductases in mammalian cells. Adv Enzymol65:97–146, 1992.
40.
Barja G. Mitochondrial oxygen radical generation and leak: Sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. J Bioenerg Biomembr31:347–366, 1999.
41.
Herrero A, Barja G. Localization of the site of oxygen radical generation inside the complex I of heart and nonsynaptic brain mammalian mitochondria. J Bioenerg Biomembr32:609–616, 2000.
42.
Robinson BH. Human complex I deficiency: Clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim Biophys Acta1364:271–286, 1998.
43.
Raha S, Robinson BH. Mitochondria, oxygen free radical, disease and ageing. Trends Biochem Sci25:502–508, 2000.
44.
Howell N. Leber hereditary optic neuropathy: how do mitochondrial DNA mutations cause degeneration of the optic nerve? J Bioenerg Biomembr29:165–173, 1997.
45.
Barrientos A, Moraes CT. Titrating the effects of mitochondrial complex I impairment in the cell physiology. J Biol Chem274:16188–16197, 1999.
46.
Wong A, Cortopassi G. MtDNA mutations confer cellular sensitivity to oxidant stress that is partially rescued by calcium depletion and cyclosporin A. Biochem Biophys Res Commun239:139–145, 1997.
47.
Brandt U. Proton-translocation by membrane-bound NADH: Ubiquinone-oxidoreductase (complex I) through redox-gated ligand conduction. Biochim Biophys Acta1318:79–91, 1997.
48.
Lenaz G. Quinone specificity of complex I. Biochim Biophys Acta1364:207–221, 1998.
49.
Degli Esposti M. Inhibitors of NADH-ubiquinone reductase: An overview. Biochim Biophys Acta1364:222–235, 1998.
50.
Fato R, Estornell E, Di Bernardo S, Pallotti F, Parenti Castelli G, Lenaz G. Steady-state kinetics of the reduction of coenzyme Q analogs by complex I in bovine heart mitochondria and submitochondrial particles. Biochemistry35:2705–2716, 1996.
51.
Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol105:429–435, 1984.
52.
Degli Esposti M, Ghelli A, Crimi M, Estornell E, Fato R, Lenaz G. Complex I and complex III of mitochondria have common inhibitors acting as ubiquinone antagonists. Biochem Biophys Res Commun190:1090–1096, 1993.
53.
Gillis JC, Benfield P, McTavish D. Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders. Drugs Aging5:133–152, 1994.
54.
Yagi T, Yano T, Di Bernardo S, Matsuno-Yagi A. Procaryotic complex I (NDH-1), an overview. Biochim Biophys Acta1364:125–133, 1998.
55.
Ohnishi T. Iron-sulfur clusters/semiquinones in complex I. Biochim Biophys Acta1364:186–206, 1998.
56.
Croft S, Gilbert BC, Lindsay-Smith JR, Whitwood AC. An ESR investigation of the reactive intermediate generated in the reaction between Fe2+ and H2O2 in aqueous solution. Direct evidence for the formation of the hydroxyl radical. Free Radic Res Commun17:21–39, 1992.
57.
Appelkvist EL, Åberg F, Guan Z, Parmryd I, Dallner G. Regulation of coenzyme Q biosynthesis. Mol Aspects Med15S:37–46, 1994.
58.
Andersson M, Ericsson J, Appelkvist EL, Schedin S, Chojnacki T, Dallner G. Modulations in hepatic branch-point enzymes involved in isoprenoid biosynthesis upon dietary and drug treatments of rats. Biochim Biophys Acta1214:79–87, 1994.
59.
Crane FL, Navas P. The diversity of coenzyme Q function. Mol Aspects Med18:s1–s6, 1997.
60.
Larm JA, Vaillant F, Linnane AW, Lawen A. Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells. J Biol Chem269:30097–30100, 1994.
61.
Morré DM, Lenaz G, Morré DJ. Surface oxidase and oxidative stress propagation in aging. J Exp Biol203:1513–1521, 2000.
62.
Kagan V, Serbinova E, Packer L. Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem Biophys Res Commun169:851–857, 1990.
63.
Ernster L, Forsmark P, Nordenbrand K. The mode of action of lipid-soluble antioxidants in biological membranes: Relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles. BioFactors3:241–248, 1992.
64.
Villalba JM, Navarro F, Cordoba F, Serrano A, Arroyo A, Crane FL, Navas P. Coenzyme Q reductase from liver plasma membrane: Purification and role in trans -plasma-membrane electron transport. Proc Natl Acad Sci USA92:4887–4891, 1995.
65.
Beyer RE, Segura-Aguilar J, Di Bernardo S, Cavazzoni M, Fato R, Fiorentini D, Galli MC, Setti M, Landi L, Lenaz G. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of Coenzyme Q in membrane systems. Proc Natl Acad Sci USA93:2528–2532, 1996.
66.
Takahashi T, Yamaguchi T, Shitashige M, Okamoto T, Kishi T. Reduction of ubiquinone in membrane lipids by rat liver cytosol and its involvement in the cellular defense system against lipid peroxidation. Biochem J309:883–890, 1995.
67.
Valls V, Castelluccio C, Fato R, Genova ML, Bovina C, Saez G, Marchetti M, Parenti Castelli G, Lenaz G. Protective effect of exogenous Coenzyme Q against damage by adriamycin in perfused rat liver. Biochem Mol Biol Int33:633–642, 1994.
68.
D’Aurelio M, Merlo Pich M, Catani L, Sgarbi G, Bovina C, Formiggini G, Parenti Castelli G, Baum H, Tura S, Lenaz G. Decreased Pasteur effect in platelets of aged individuals. Mech Ageing Dev122:823–833, 2001.
69.
Lenaz G, Paolucci U, Fato R, D’Aurelio M, Parenti Castelli G, Sgarbi G, Biagini G, Ragni L, Salardi S, Cacciari E. Enhanced activity of the plasma membrane oxidoreductase in circulating lymphocytes from insulin-dependent diabetes mellitus patients. Biochem Biophys Res Commun290:1589–1592, 2002.
70.
Low PA, Nickander KK, Tritschler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes46:S38–S42, 1997.
71.
Kalén A, Söderberg M, Elmberger PG, Dallner G. Uptake and metabolism of dolichol and cholesterol in perfused rat liver. Lipids25:93–99, 1990.
72.
Beyer RE, Burnett BA, Cartwright KJ, Edington DW, Falzon MJ, Kreitman KR, Kuhn TW, Ramp BJ, Rhee SYS, Rosenwasser MJ, Stein M, An LCI. 1. Tissue Coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory rat. Mech Ageing Dev32:267–281, 1985.
73.
Battino M, Gorini A, Villa RF, Genova ML, Bovina C, Sassi S, Littarru GP, Lenaz G. Coenzyme Q content in synaptic and nonsynaptic mitochondria from different brain regions of the ageing rat. Mech Ageing Dev78:173–187, 1995.
74.
Söderberg M, Edlund C, Alafuzoff I, Kristensson K, Dallner G. Lipid composition of different regions of the human brain during aging. J Neurochem54:415–423, 1990.
75.
Andersson M, Åberg F, Teclebhran H, Edlund C, Appelkvist EL. Age-dependent modifications in the metabolism of mevalonate pathway lipids in rat brain. Mech Ageing Dev85:1–14, 1995.
76.
Formiggini G, Castelluccio C, Merlo Pich M, Genova ML, Bovina C, Marchetti M, Lenaz G. Coenzyme Q depletion in rat plasma after partial hepatectomy. Biochem Mol Biol Int39:1135–1140, 1996.
Blasi MA, Bovina C, Carella G, Genova ML, Jansen AM, Lenaz G, Brancato R. Does coenzyme Q10 play a role in opposing oxidative stress in patients with age-related macular degneration? Ophthalmologica215:51–54, 2001.
81.
Beal MF. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases. BioFactors9:261–266, 1999.
82.
Karlsson J, Diamant B, Theorell H, Folkers K. Ubiquinone and alpha-tocopherol in plasma; means of translocation or depot. Clin Invest71S:84–91, 1993.
83.
Zhang Y, Turunen M, Appelkvist EL. Restricted uptake of dietary coenzyme Q is in contrast to the unrestricted uptake of alpha-tocopherol into rat organs and cells. J Nutr126:2089–2097, 1996.
84.
Huertas JR, Martinez-Velasco E, Ibanez S, Lopez-Frias M, Ochoa JJ, Quiles J, Parenti Castelli G, Mataix J, Lenaz G. Virgin olive oil and coenzyme Q10 protect heart mitochondria from peroxidative damage during aging. Biofactors9:337–344, 1999.
